MyAverix Finance
TO · Healthcare
Cardiol Therapeutics Inc Class A (CRDL)
Drug Manufacturers - Specialty & Generic
Cardiol Therapeutics Inc Class A (CRDL) is listed on TO in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-05-24, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for CRDL
Cardiol Therapeutics Inc Class A (CRDL) — FAQ
What is CRDL's P/E ratio?
The price-to-earnings (P/E) ratio for Cardiol Therapeutics Inc Class A (CRDL) is 18.00 (data as of 2026-05-24).
Does Cardiol Therapeutics Inc Class A pay a dividend?
Dividend yield is not available in the current snapshot for Cardiol Therapeutics Inc Class A (CRDL). Check the MyAverix Finance app for the latest dividend data.
What sector is Cardiol Therapeutics Inc Class A in?
Cardiol Therapeutics Inc Class A (CRDL) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is CRDL listed on?
CRDL is listed on TO.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.